Background: Monitoring allergic rhinitis (AR) severity with objective biomarkers is important for the clinical management of patients as well as for research purposes. The most commonly used tool for the assessment of AR severity is the Total Nasal Symptom Score (TNSS). Objective biomarkers like skin prick test size or specific IgE levels do not correlate with TNSS. Objective: We hypothesize that the psychological factors are the missing link between patient-perceived severity of AR and objective biomarkers. Method: Thirty-nine patients (median age: 34 years; 21 [54%] female) with grass pollen-related AR were enrolled in our study. Patients allergic for perennial allergens and allergens with potentially overlapping seasons including cypress, ash/olive, plane, and nettle families were excluded. Patient-reported outcomes included symptom score, medication scores, combined score, and Juniper Mini Rhinitis Quality of Life Questionnaire (minRQLQ). Psychometric evaluation was performed using 5 different psychological questionnaires that measure 13 different psychological factors. Results: There was a significant correlation between the symptom score and private body consciousness (r = 0.50, p = 0.001) and neuroticism (R = 0.41 and p = 0.01). There was also a statistically significant correlation between the combined score and private body consciousness (r = 0.49 and p = 0.001) and with perceiving and understanding emotions (r = 0.34 and p = 0.04). The miniRQLQ score had a positive correlation with private body consciousness (r = 0.55 and p = 0.002) and observing (r = 0.42 and p = 0.02). Conclusions: Our data suggest that patients who are more aware of internal stimuli, as well as those who are highly self-conscious and somatically concerned tend to experience more severe AR symptoms.

Keywords:
Grass pollen allergy, Seasonal allergic rhinitis, Patient outcome assessment, Psychological factors
1.
Shamji MH, Kappen JH, Akdis M, Knol EF. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma : an EAACI Position Paper. Allergy. 2017;72(8):1156–73.
2.
Meltzer EO, Wallace D, Dykewicz M, Shneyer L. Minimal Clinically Important Difference (MCID) in allergic rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds? J Allergy Clin Immunol Pract. 2016;4(4):682–8.e6.
3.
Bavbek S, Kumbasar H, Tuğcu H, Misirligil Z. Psychological status of patients with seasonal and perennial allergic rhinitis. J Investig Allergol Clin Immunol. 2002;12(3):204–10.
4.
Greif Y, Goldberg A, Tamir R, Vigiser D, Melamed S. Skin test results and self-reported symptom severity in allergic rhinitis: the role of psychological factors clinical and experimental allergy. Clin Exp Allergy. 2006;36:1532–7.
5.
Miller LC, Murphy R, Buss AH. Consciousness of body: private and public. J Pers Soc Psychol. 1981;41(2):397–406.
6.
Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2016 revision. J Allergy Clin Immunol. 2017;140(4):950–8.
7.
Lamers SMA, Westerhof GJ, Bohlmeijer ET, Ten Klooster PM, Keyes CLM. Evaluating the psychometric properties of the mental health Continuum-Short Form (MHC-SF). J Clin Psychol. 2011;67(1):99–110.
8.
Kemper CJ, Rammstedt B. Psychometric properties of the BFI-K: a cross-validation study. Int J Educ Psychol. 2013;13(1):34–50.
9.
Baer RA, Smith GT, Allen KB. Assessment of mindfulness by self-report the Kentucky inventory of mindfulness skills. Assesment. 2004;11(3):191–206.
10.
Duran M. Emotional skills and competence questionnaire (ESCQ) as a self-report measure of emotional intelligence. Horiz Psychol. 2009;21:7–21.
© 2022 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2022
You do not currently have access to this content.